genOway signs exclusive US distribution deal with Taconic Biosciences for humanized models
Bitget2026/09/23 16:02- genOway signed an exclusive U.S. distribution agreement with Taconic Biosciences to expand sales of its humanized preclinical models.
- Taconic will resell products purchased from genOway, making each Taconic sale incremental revenue for genOway.
- Deal terms aim to keep profitability close to direct sales, supporting near-term earnings leverage.
- Management flagged potential to double U.S. activity, its largest market with more than 50% of sales.
- Partnership adds nationwide U.S. commercial coverage through Taconic’s sales network, accelerating penetration of a market estimated above USD 1 billion annually.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canton Network breaks 2 month range! – CC’s run to $0.15 depends on THIS zone
Analysis: Wall Street Is Not Yet Ready to Short AI in Large Numbers
Overseas capital is aggressively buying US stocks! Net inflows reached $942 billions over the past 12 months, marking a record since 1985.
According to data from the US Department of the Treasury, in the 12 months ending July this year, overseas investors made net purchases of US stocks totaling $942 billion, marking the highest rolling 12-month total since records began in 1985. The net purchases in the second quarter alone reached $426 billion, setting a new single-quarter record. Meanwhile, overseas demand for US Treasuries has noticeably cooled, with purchase volumes falling significantly. As a result, the US is facing higher costs in government debt financing.
Crypto prices
More
